
Improving the treatment of the novel coronavirus infection (COVID-19) in children at risk for the development of severe disease with the use of virus-neutralizing monoclonal antibodies
Author(s) -
А. С. Токарев,
И. М. Османов,
Л. Н. Мазанкова,
И. Н. Захарова,
Э. Р. Самитова,
S. O. Kotenko
Publication year - 2022
Publication title -
rossijskij vestnik perinatologii i pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.139
H-Index - 4
eISSN - 2500-2228
pISSN - 1027-4065
DOI - 10.21508/1027-4065-2022-67-3-23-33
Subject(s) - medicine , coronavirus , monoclonal antibody , covid-19 , disease , antibody , neutralizing antibody , virus , virology , immunology , infectious disease (medical specialty)